BioSpace News Archive

Dynatronics Corporation (NASDAQ : DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced preliminary unaudited net sales for the fiscal fourth quarter ended June 30, 2020 and the fiscal year ended June 30, 2020. Fourth Quarter & Year End 2020 Update Preliminary unaudited fourth quarter 2020 net sales are expected to be in the range of $7.9 million to $8.2 million, a 47% - 49% de

COMPANY ALSO ANNOUNCES IT IS CURRENTLY EVALUATING ADDITIONAL AGREEMENTS FOR DISTRIBUTION OF GENVIRO! SWIFT KITS IN BRAZIL, ARGENTINA, NIGERIA AND THE PHILIPPINES, AND THAT IT HAS FILED A PROVISIONAL PATENT FOR ITS GENULTIMATE TBG PRODUCT

Caligor Coghlan Pharma Services to Distribute Strontium89 (Strontium Chloride Injection Sr-89 USP) Outside the United States Agreement opens international markets ahead of schedule under Named Patient Program

JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties, continues to broaden the medical and clinical competency of its scientific advisory board.

Cohorts of younger adults (n=300) and older adults (n=300) in Phase 2 study fully enrolled Cohorts of older adults (ages 56-70, n=30) and elderly adults (ages 71 and above, n=30) in NIH-led Phase 1 study completed enrollment; results expected to be published once available Pivotal Phase 3 study expected to begin in July; manufacture of vaccine required to start Phase 3 study completed CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Moderna, Inc.

RefleXion Medical , a therapeutic oncology company pioneering biology-guided radiotherapy* ( BgRT ) as a new modality for treating all stages of cancer, and Telix Pharmaceuticals Limited (ASX: TLX), a radiopharmaceutical company developing molecularly-targeted radiation ( MTR ) products, today announced a strategic collaboration to investigate the clinical utility of combining the companies’

Cend Therapeutics, Inc. (formerly DrugCendR, Inc.), a clinical-stage biotech company, announced today changes in the senior management of the company. David Slack, MBA will take over as President and CEO. Erkki Ruoslahti, MD, PhD, co-founding CEO will remain Chairman and serve as a senior advisor for the Company. Mr. Slack has over 25 years of experience in the biotech and pharmaceutical industry having served in senior positions in s

The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals have granted Eugenia Trushina , Ph.D., of Mayo Clinic Rochester, the ADDF-Harrington Sch

In a time when the world is facing unparalleled uncertainty surrounding COVID-19, it has become increasingly apparent how integral the life sciences sector is to our society. The life sciences sector is at the forefront globally in combating the spread and developing vaccines and treatments to slow the pandemic.

With COVID-19 cases spiking just as businesses are beginning to recover from shutdowns, many Arizona employers are facing very real risks in reopening.